| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | T8B2ORP1DW |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hyperlipoproteinemia Type II | 4 | D006938 | ClinicalTrials |
| Hypertriglyceridemia | 2 | D015228 | ClinicalTrials |
| Hypercholesterolemia | 2 | D006937 | ClinicalTrials |
| Metabolic Diseases | 1 | D008659 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1446419-85-7 |
| ChEMBL | CHEMBL3545191 |
| FDA SRS | T8B2ORP1DW |
| Guide to Pharmacology | 8717 |
CONTENTS